We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTSH icon
126
Cognizant
CTSH
$20.3B
$1.38M 0.38%
+22,418
New +$1.6M
DASH icon
127
DoorDash
DASH
$74B
$1.37M 0.38%
9,152
+1,856
+25% +$343K
IOVA icon
128
Iovance Biotherapeutics
IOVA
$2.29B
$1.35M 0.37%
383,763
+73,122
+24% +$234K
APLS
129
DELISTED
Apellis Pharmaceuticals
APLS
$1.35M 0.37%
33,462
+6,376
+24% +$137K
OCCI
130
OFS Credit Co
OCCI
$69M
$1.34M 0.37%
462,155
+40,922
+10% +$156K
AXON
131
Axon Enterprise
AXON
$39.6B
$1.32M 0.36%
3,109
+583
+23% +$303K
HOOD icon
132
Robinhood
HOOD
$91.2B
$1.25M 0.34%
18,033
+4,990
+38% +$438K
CVNA icon
133
Carvana
CVNA
$43.1B
$1.25M 0.34%
19,860
-6,475
-25% -$480K
ERAS icon
134
Erasca
ERAS
$6.71B
$1.23M 0.34%
75,746
+1,850
+3% +$21.9K
MIRM icon
135
Mirum Pharmaceuticals
MIRM
$6.97B
$1.2M 0.33%
12,987
+2,474
+24% +$233K
BCRX icon
136
BioCryst Pharmaceuticals
BCRX
$2.38B
$1.06M 0.29%
111,529
+21,251
+24% +$165K
ROIV icon
137
Roivant Sciences
ROIV
$25.2B
$1.06M 0.29%
38,202
+7,280
+24% +$187K
AGIO icon
138
Agios Pharmaceuticals
AGIO
$2.16B
$1.05M 0.29%
30,959
+5,899
+24% +$167K
NVAX icon
139
Novavax
NVAX
$1.29B
$1.05M 0.29%
128,505
+24,486
+24% +$222K
UTHR icon
140
United Therapeutics
UTHR
$26.4B
$1.01M 0.28%
1,707
+325
+24% +$162K
KALV
141
DELISTED
KalVista Pharmaceuticals
KALV
$1.01M 0.28%
49,927
+9,513
+24% +$153K
KNSA icon
142
Kiniksa Pharmaceuticals
KNSA
$4.85B
$977K 0.27%
20,300
+3,868
+24% +$171K
SNDX icon
143
Syndax Pharmaceuticals
SNDX
$1.88B
$968K 0.27%
41,445
+7,896
+24% +$172K
AXSM icon
144
Axsome Therapeutics
AXSM
$12.4B
$963K 0.27%
5,698
+1,087
+24% +$188K
XFLT
145
XAI Floating Rate & Alternative Income Trust
XFLT
$269M
$958K 0.26%
55,758
+7,310
+15% +$144K
GERN icon
146
Geron
GERN
$930M
$925K 0.26%
620,795
+118,286
+24% +$180K
TGTX icon
147
TG Therapeutics
TGTX
$8.5B
$895K 0.25%
26,930
+5,131
+24% +$153K
BMRN icon
148
BioMarin Pharmaceuticals
BMRN
$11.4B
$895K 0.25%
15,836
+3,018
+24% +$176K
ZLAB icon
149
Zai Lab
ZLAB
$2.22B
$894K 0.25%
47,511
+9,054
+24% +$168K
TCPC icon
150
BlackRock TCP Capital
TCPC
$263M
$893K 0.25%
247,315
+34,981
+16% +$162K
4 5
6
7 8

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.